Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources

 

Medical Encyclopedia

Other encyclopedia topics:  A-Ag  Ah-Ap  Aq-Az  B-Bk  Bl-Bz  C-Cg  Ch-Co  Cp-Cz  D-Di  Dj-Dz  E-Ep  Eq-Ez  F  G  H-Hf  Hg-Hz  I-In  Io-Iz  J  K  L-Ln  Lo-Lz  M-Mf  Mg-Mz  N  O  P-Pl  Pm-Pz  Q  R  S-Sh  Si-Sp  Sq-Sz  T-Tn  To-Tz  U  V  W  X  Y  Z  0-9 

Hodgkin’s lymphoma

Printer-friendly versionEmail this page to a friend
Contents of this page:

Illustrations

Lymphatic system
Lymphatic system
Lymphoma, malignant - CT scan
Lymphoma, malignant - CT scan
Hodgkin's disease, liver involvement
Hodgkin's disease, liver involvement
Immune system structures
Immune system structures

Alternative Names    Return to top

Lymphoma - Hodgkin's; Hodgkin's disease; Cancer - Hodgkin's lymphoma

Definition    Return to top

Hodgkin's lymphoma is a malignancy (cancer) of lymph tissue found in the lymph nodes, spleen, liver, and bone marrow.

Causes    Return to top

The first sign of this cancer is often an enlarged lymph node which appears without a known cause. The disease can spread to nearby lymph nodes and later may spread to the lungs, liver, or bone marrow.

The cause is not known. Hodgkin's lymphoma is most common among people 15 - 35 and 50 - 70 years old.

Symptoms    Return to top

Additional symptoms that may be associated with this disease:

Exams and Tests    Return to top

The disease may be diagnosed after:

A staging evaluation (tumor staging) may be done to determine the extent of the disease. The following procedures may be done:

In some cases, abdominal surgery to take a piece of the liver and remove the spleen may be needed. However, because the other tests are now so good at detecting the spread of Hodgkin's lymphoma, this surgery is usually unnecessary.

Hodgkin's lymphoma may change the results of the following tests:

Treatment    Return to top

Treatment primarily depends on the following:

A staging evaluation is necessary to determine the treatment plan.

Treatment varies with the stage of the disease. Stages I and II (limited disease) can be treated with localized radiation therapy, with chemotherapy or with a combination of both. Stages III and IV (extensive disease) are treated with chemotherapy alone or a combination of radiation therapy and chemotherapy. The best treatment for an individual patient depends on many factors, and should be discussed in detail with a doctor who has experience treating this disease.

Chemotherapy can cause low blood cell counts, which can lead to an increased risk of bleeding, infection, and anemia. To minimize bleeding, apply ice and pressure to any external bleeding. A soft toothbrush and electric razor should be used for personal hygiene.

Infection should always be taken seriously during cancer treatment, so contact your doctor immediately if fever or other signs of infection develop. Planning daily activities with scheduled rest periods may help prevent fatigue associated with anemia.

Support Groups    Return to top

The stress of illness can often be eased by joining a support group of people sharing common experiences and problems. See cancer - support group.

Outlook (Prognosis)    Return to top

With appropriate treatment, more than 80% of people with stage I or II Hodgkin's survive for at least 10 years. With widespread disease, the treatment is more intense and the 5-year survival rate is about 60%.

Possible Complications    Return to top

When to Contact a Medical Professional    Return to top

Call your health care provider if you have symptoms suggestive of Hodgkin's lymphoma.

Call your health care provider if you are being treated for Hodgkin's lymphoma and experience adverse effects of radiation and chemotherapy, including nausea, loss of appetite, vomiting, diarrhea, fever, or bleeding.

References    Return to top

Fermé C, Eghbali H, Meerwaldt JH, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med. Nov 8, 2007;357(19):1916-27.

Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. Feb 10, 2007;25(5):571-8. Epub 2007 Jan 22.

National Cancer Institute. Adult hodgkin lymphoma treatment (PDQ). 2008. Accessed June 10, 2008.

Update Date: 6/10/2008

Updated by: James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M. Logo

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.